Eli Lilly stock rises after late-stage trial of next-generation weight-loss drug
- Posted on June 8, 2026
- By Bing News
- 0 Views
- 1 min read
Eli Lilly stock rises after late-stage trial of next-generation weight-loss drug
Eli Lilly shares gained on Monday, after a late-stage trial of its next-generation weight-loss drug impressed analysts.
